Corticotropin-releasing factor testing reveals a dose-dependent difference in methadone maintained vs control subjects

Keyphrases

• Methadone 100%
• Dose Effect 100%
• Control Subjects 100%
• Corticotropin-releasing Factor 100%
• HPA Axis 75%
• Adrenocorticotropic Hormone 75%
• Placebo 50%
• High Dose 50%
• Addiction 50%
• Methadone Maintenance Treatment 50%
• Responsivity 50%
• One Dose 50%
• Two-dose 25%
• Opiate Addiction 25%
• Heroin 25%
• Stress-responsive 25%
• Ultra-low Dose 25%
• No Significant Difference 25%
• Hormone Levels 25%
• Stable Dose 25%
• Clinical Diagnostics 25%
• Male Volunteers 25%
• Hypothalamic-pituitary-adrenal Axis Function 25%
• Neuroendocrine Function 25%
• Heroin Addiction 25%
• Heroin Addicts 25%
• Metyrapone 25%
• Methadone Treatment 25%

Pharmacology, Toxicology and Pharmaceutical Science

• Corticotropin Releasing Factor 100%
• Methadone 100%
• Corticotropin 75%
• Placebo 50%
• Heroin Dependence 50%
• Methadone Treatment 25%
• Opiate Addiction 25%
• Diamorphine 25%
• Sphingolipid Activator Protein 2 25%
• Metyrapone 25%
• Dexamethasone 25%

Neuroscience

• Corticotropin-Releasing Hormone 100%
• Methadone 100%
• Hypothalamic-Pituitary-Adrenal Axis 80%
• Adrenocorticotropic Hormone 60%
• Heroin Dependence 40%
• Placebo 40%
• Dexamethasone 20%
• Metyrapone 20%
• Heroin 20%
• Opioid Dependence 20%
• Sphingolipid Activator Protein 2 20%